Author

W. Fendler

OpenAlex ID: A5043809399

P0827 Impact of negative primary staging with PSMA-PET versus conventional imaging among patients with lymph node invasion after radical prostatectomy

2026 · F.M. Barletta, G. Marra, et al. · European Urology

A0554 Identifying candidates for radical prostatectomy and extended pelvic lymph node dissection among prostate cancer patients with PSMA-PET–detected nodal disease (miN1): The combined role of MRI staging and quantitative PSMA parameters

2026 · S.L.A. Scuderi, G. Marra, et al. · European Urology

P0359 PSMA imaging-based stratification of men with high-risk prostate cancer candidates for radical prostatectomy: Beyond clinical risk factors

2026 · F.M. Barletta, G. Marra, et al. · European Urology

PSMA-PET vs. conventional imaging for preoperative staging high-risk PCa patients underwent surgery for cN0M0 disease: an European Association of Urology-Young Academic Urologists Prostate Cancer Working Group multi-institutional study

2025 · M. Droghetti, L. Bianchi, et al. · European Urology Open Science

A0459 – Is there an oncological benefit of extended pelvic lymph node dissection at the time of radical prostatectomy in PSMA-PET node negative prostate cancer patients? Results from a multi-institutional cohort

2025 · S.L.A. Scuderi, F. Barletta, et al. · European Urology

External validation of the available nomograms for the identification of candidates for a staging extended pelvic lymph node dissection at the time of radical prostatectomy in prostate cancer patients preoperatively staged with PSMA PET

2024 · F.M. Barletta, G. Gandaglia, et al. · European Urology

99P Fibroblast activation protein alpha (FAP) as theranostic target in solitary fibrous tumor

2023 · R.W. Hamacher, K.M. Pabst, et al. · ESMO Open

Improving prediction of local stage by PSMA-PET: Development of a novel integrated tool for extracapsular extension and seminal vesicle invasion combining clinical and imaging features in localized prostate cancer

2023 · S.L.A. Scuderi, G. Gandaglia, et al. · European Urology

Identifying the optimal candidates for a super-extended staging pelvic lymph-node dissection in prostate cancer patients treated in the PET-PSMA era. Results from a multi-institutional series

2023 · F.M. Barletta, G. Gandaglia, et al. · European Urology

Can we rely on available models to identify candidates for extended Pelvic Lymph Node Dissection (ePLND) in men staged with PSMA-PET? External validation of the Briganti nomograms and development of a novel tool to identify optimal candidates for ePLND

2023 · G. Gandaglia, D. Robesti, et al. · European Urology

PSMA PET disease extent for European Association of Urology biochemical recurrence risk groups: An international multicentre study

2022 · W. Fendler, J. Ferdinandus, et al. · European Urology

Works count: 13

Citation count:

H-index:

I10-index: